MET fusions are well-established oncogenic drivers in other malignancies, and their presence in thyroid cancer represents an alternative mechanism to tumorigenesis. By documenting this case, we aim to expand the molecular characterization of fusion-driven thyroid tumors and highlight the importance of continued surveillance and reporting of such rare alterations. Here, MET is linked to thyroid cancer.